Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance. [electronic resource]
Producer: 20150305Description: 390-402 p. digitalISSN:- 1476-5586
- Antineoplastic Agents, Hormonal
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- genetics
- Cell Line, Tumor
- Drug Resistance, Neoplasm -- physiology
- Female
- Humans
- Image Processing, Computer-Assisted
- Immunohistochemistry
- In Vitro Techniques
- Kaplan-Meier Estimate
- Mass Spectrometry -- methods
- Metabolome
- Metabolomics -- methods
- Oligonucleotide Array Sequence Analysis
- Prognosis
- Ribonucleoside Diphosphate Reductase -- genetics
- Tamoxifen
- Tissue Array Analysis
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.